Efficacy and Safety of Ruxolitinib in Steroid-Refractory/Dependent Chronic Graft-versus-Host Disease: Real-World Data and Challenges-Reference-Cited by-同舟云学术

Efficacy and Safety of Ruxolitinib in Steroid-Refractory/Dependent Chronic Graft-versus-Host Disease: Real-World Data and Challenges

Published:2022-01 Issue:1 Volume:28 Page:43.e1-43.e5
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Redondo Sara,Esquirol Albert,Novelli Silvana,Caballero Ana Carolina^ORCID,Garrido Ana,Oñate Guadalupe,López Jordi,Moreno Carol,Saavedra Silvanna-Daniela,Granell Miquel,Briones Javier,Sierra Jorge,Martino Rodrigo,García-Cadenas Irene

Funder

Ministerio de Economía y Competitividad

Instituto de Salud Carlos III

Fundacio la Marato de TV3

Agència de Gestió d'Ajuts Universitaris i de Recerca

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference26 articles.

1. Chronic graft versus host disease;Baird;Curr Opin Hematol,2006

2. Long-term complications and side effects after allogeneic hematopoietic stem cell transplantation: an update;Mohty;Blood Cancer J,2011

3. Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease;Wolff;Biol Blood Marrow Transplant,2011

4. First and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation;Martin;Biol Blood Marrow Transplant,2012

5. Treatment of patients with steroid refractory acute graft vs host disease (SR-GVHD): a matched paired analysis of anti-CD26 (begelomab) compared to other treatment;Bacigalupo;Blood,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates in chronic graft-versus-host disease: novel treatments and best practices in the current era;Bone Marrow Transplantation;2024-07-31

2. Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis;Annals of Hematology;2024-06-25

3. ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-versus-host disease in adults;European Respiratory Journal;2024-03

4. Ruxolitinib in patients with graft versus host disease (GvHD): findings from a compassionate use program;Bone Marrow Transplantation;2024-02-15

5. Ruxolitinib as the first post-steroid treatment for acute and chronic graft-versus-host disease;Expert Review of Clinical Immunology;2023-08-22